20 High Growth Mega Cap Stocks You Can Buy And Hold For Next 5 Years

18. Eli Lilly and Company (NYSE:LLY) 

Eli Lilly and Company is a developer, explorer, and marketer of human pharmaceuticals. The company offers a wide range of products including Humalog, Zepbound for obesity, oncology products, Olumiant for rheumatoid arthritis, Basaglar, Cymbalta for depressive disorder, and other products. The company has grown its revenue by 15.54% over the last 5 years.

The company entered into a global licensing deal with South Korea’s OliX Pharmaceuticals that could be valued at up to $630 million. As per the agreement, Eli Lilly will offer financial assistance for the successful completion of the phase 1 trial of the company’s experimental MASH treatment.

The company also entered into a partnership with OpenAI to use AI for drug exploration. The collaboration will aid in drug discovery, an area many firms are focusing on since the emergence of AI.

Sales of the company’s flagship Mounjaro and Zepbound are expected to stay strong this year as well. With additional manufacturing capacity coming online, the company is expected to continue growing in the next 5 years.